CTLA-4+CD8+ T Cells That Encounter B7-2+ Iris Pigment Epithelial Cells Express Their Own B7-2 to Achieve Global Suppression of T Cell Activation

Journal of Immunology

Volumn 172, Issue 7, 2004, Pages 4184-4194

  Sugita, Sunao ^a   Ng, Tat Fong ^a   Schwartzkopff, Johannes ^a   Streilein, J Wayne ^a  

^a SCHEPENS EYE RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD28 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CD86 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; MESSENGER RNA; T LYMPHOCYTE RECEPTOR; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; CILIARY BODY; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IRIS; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PARENCHYMA; PIGMENT CELL; PIGMENT EPITHELIUM; PRIORITY JOURNAL; SPLEEN LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

EID: 1642310491     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.172.7.4184     Document Type: Article

References (24)

1. Taylor, A. W. 1999. Ocular immunosuppressive microenvironment. Chem. Immunol. 73:72.
2. Kaiser, C. J., B. R. Ksander, and J. W. Streilein. 1989. Inhibition of lymphocyte proliferation by aqueous humor. Reg. Immunol. 2:42.
3. Streilein, J. W. 1993. Immune privilege as the result of local tissue barriers and immunosuppressive microenvironments. Curr. Opin. Immunol. 5:428.
4. Stuart, P. M., T. S. Griffith, N. Usui, J. Pepose, X. Yu, and T. A. Ferguson. 1997. CD95 ligand (FasL)-induced apoptosis is necessary for corneal allograft survival. J. Clin. Invest. 99:396.
5. Yamagami, S., H. Kawashima, T. Tsuru, H. Yamagami, N. Kayagaki, H. Yagita, K. Okumura, and D. S. Gregerson. 1997. Role of Fas-Fas ligand interactions in the immunorejection of allogeneic mouse corneal transplants. Transplantation 64:1107.
6. Streilein, J. W. 2003. Ocular immune privilege: therapeutic opportunities from an experiment of nature. Nat. Rev. Immunol. 3:879.
7. Niederkorn, J. Y. 2002. Immune privilege in the anterior chamber of the eye. Crit. Rev. Immunol. 22:13.
8. Camacho-Hubner, A., and F. Beermann. 2001. Increased transgene expression by the mouse tyrosinase enhancer is restricted to neural crest-derived pigment cells. Genesis 29:180.
9. Rothermel, A., and P. G. Layer. 2001. Photoreceptor plasticity in reaggregates of embryonic chick retina: rods depend on proximal cones and on tissue organization. Eur. J. Neurosci. 13:949.
10. Yoshida, M., M. Takeuchi, and J. W. Streilein. 2000. Participation of pigment epithelium of iris and ciliary body in ocular immune privilege. 1. Inhibition of T-cell activation in vitro by direct cell-to-cell contact. Invest. Ophthalmol. Vis. Sci. 41:811.
11. Yoshida, M., T. Kezuka, and J. W. Streilein. 2000. Participation of pigment epithelium of iris and ciliary body in ocular immune privilege. 2. Generation of regulatory T cells that suppress bystander T cells via TGF-β. Invest. Ophthalmol. Vis. Sci. 41:3862.
12. Ishida, K., N. Panjwani, Z. Cao, and J. W. Streilein. 2003. Participation of pigment epithelium of iris and ciliary body in ocular immune privilege. 3. Epithelia cultured from iris, ciliary body, and retina suppress T cell activation by partially non-overlapping mechanisms. Ocul. Immunol. Inflamm. 11:91.
13. Sugita, S., and J. W. Streilein. 2003. Iris pigment epithelium expressing CD86 (B7-2) directly suppresses T cell activation in vitro via binding to CTLA-4. J. Exp. Med. 198:161.
14. Weston, S. A., and C. R. Parish. 1990. New fluorescent dyes for lymphocyte migration studies. Analysis by flow cytometry and fluorescence microscopy. J. Immunol. Methods 133:87.
15. Kingsley, D. M. 1994. The TGF-β superfamily: new members, new receptors, and new genetic tests of function in different organisms. Genes Dev. 8:133.
16. Zhao, Y., and S. L. Young. 1996. Requirement of transforming growth factor-β (TGF-β) type II receptor for TGF-β-induced proliferation and growth inhibition. J. Biol. Chem. 271:2369.
17. Carreno, B. M., and M. Collins. 2002. The B7 family of ligands and its receptors: new pathways for costimulation and inhibition of immune responses. Annu. Rev. Immunol. 20:29.
18. Freeman, G. J., A. J. Long, Y. Iwai, K. Bourque, T. Chernova, H. Nishimura, L. J. Fitz, N. Malenkovich, T. Okazaki, M. C. Byrne, et al. 2000. Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J. Exp. Med. 192:1027.
19. Latchman, Y., C. R. Wood, T. Chemova, D. Chaudhary, M. Borde, I. Chemova, Y. Iwai, A. J. Long, J. A. Brown, R. Nunes, et al. 2001. PD-L2 is a second ligand for PD-1 and inhibits T cell activation. Nat. Immunol. 2:261.
20. Watanabe, N., M. Gavrieli, J. R. Sedy, J. Yang, F. Fallarino, S. K. Loftin, M. A. Hurchla, N. Zimmerman, J. Sim, X. Zang, et al. 2003. BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1. Nat. Immunol. 4:670.
21. + T cells. Eur. J. Immunol. 28:865.
22. Tatari-Calderone, Z., R. T. Semnani, T. B. Nutman, J. Schlom, and H. Sabzevari. 2002. Acquisition of CD80 by human T cells at early stages of activation: functional involvement of CD80 acquisition in T cell to T cell interaction. J. Immunol. 169:6162.
23. + regulatory T cells is mediated by cell surface-bound transforming growth factor β. J. Exp. Med. 194:629.
24. + T cells. J. Exp. Med. 188:1849.